Lotzová E - Search Results

1

Randomized comparison of viral oncolysate plus radiation and radiation alone in uterine cervix carcinoma.

Freedman RS, Bowen JM, Atkinson EN, Wallace S, Lotzová E, Silva E, Edwards CL, Delclos L, Scott W, Patenia B, et al. Freedman RS, et al. Among authors: lotzova e. Am J Clin Oncol. 1989 Jun;12(3):244-50. doi: 10.1097/00000421-198906000-00013. Am J Clin Oncol. 1989. PMID: 2499178 Clinical Trial.

2

Viral oncolysates in patients with advanced ovarian cancer.

Freedman RS, Edwards CL, Bowen JM, Lotzova E, Katz R, Lewis E, Atkinson N, Carsetti R. Freedman RS, et al. Among authors: lotzova e. Gynecol Oncol. 1988 Mar;29(3):337-47. doi: 10.1016/0090-8258(88)90233-8. Gynecol Oncol. 1988. PMID: 3345954

3

Comparison of recombinant-interleukin-2-activated peripheral blood and tumor-infiltrating lymphocytes of patients with epithelial ovarian carcinoma: cytotoxicity, growth kinetics and phenotype.

Lotzová E, Savary CA, Freedman RS, Edwards CL, Morris M. Lotzová E, et al. Cancer Immunol Immunother. 1990;31(3):169-75. doi: 10.1007/BF01744732. Cancer Immunol Immunother. 1990. PMID: 2337905 Free PMC article.

4

Effect of virus-modified tumor cell extracts, autologous mononuclear cell infusions and interleukin-2 on oncolytic activity of effector cells of patients with advanced ovarian cancer.

Furukawa K, Lotzová E, Freedman RS, Bowen JB, Edwards CL, Wharton JT. Furukawa K, et al. Among authors: lotzova e. Cancer Immunol Immunother. 1989;30(2):126-32. doi: 10.1007/BF01665964. Cancer Immunol Immunother. 1989. PMID: 2598179 Free PMC article.

5

Recombinant IL-2-activated NK cells mediate LAK activity against ovarian cancer.

Lotzová E, Savary CA, Freedman RS, Edwards CL, Wharton JT. Lotzová E, et al. Int J Cancer. 1988 Aug 15;42(2):225-31. doi: 10.1002/ijc.2910420214. Int J Cancer. 1988. PMID: 3261280

6

Natural killer cell cytotoxic potential of patients with ovarian carcinoma and its modulation with virus-modified tumor cell extract.

Lotzová E, Savary CA, Freedman RS, Bowen JM. Lotzová E, et al. Cancer Immunol Immunother. 1984;17(2):124-9. doi: 10.1007/BF00200048. Cancer Immunol Immunother. 1984. PMID: 6205745 Free PMC article.

7

Natural immunity against ovarian tumors.

Lotzová E, Savary CA, Freedman R, Bowen JM. Lotzová E, et al. Comp Immunol Microbiol Infect Dis. 1986;9(2-3):269-75. doi: 10.1016/0147-9571(86)90021-4. Comp Immunol Microbiol Infect Dis. 1986. PMID: 3491727

8

Oncolytic activity of NK cells against SW-756 squamous cervical carcinoma cell line: role of interferons alpha and gamma and CD54 adhesion molecule in oncolysis.

Cristoforoni PM, Lotzová E, Cook KR, Chuang LT, Morris M, Grossi CE, Wharton JT. Cristoforoni PM, et al. Among authors: lotzova e. Gynecol Oncol. 1994 Mar;52(3):365-72. doi: 10.1006/gyno.1994.1063. Gynecol Oncol. 1994. PMID: 7512522

9

Natural immunity in breast cancer patients during neoadjuvant chemotherapy and after surgery.

Beitsch P, Lotzová E, Hortobagyi G, Pollock R. Beitsch P, et al. Among authors: lotzova e. Surg Oncol. 1994 Aug;3(4):211-9. doi: 10.1016/0960-7404(94)90036-1. Surg Oncol. 1994. PMID: 7834112

10

Generation of cytotoxic NK cells in peripheral blood and bone marrow of patients with acute myelogenous leukemia after continuous infusion with recombinant interleukin-2.

Lotzová E, Savary CA, Schachner JR, Huh JO, McCredie K. Lotzová E, et al. Am J Hematol. 1991 Jun;37(2):88-99. doi: 10.1002/ajh.2830370206. Am J Hematol. 1991. PMID: 2069169

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters